Drug LitigationPfizer’s Zoloft Raises Questions about Safety during Pregnancy

March 9, 2012

Pharmaceudical giant Pfizer, Inc. has manufactured Zoloft (sertraline) for 21 years and filled as much as 27 million prescriptions annually. Despite the long-standing popularity of this SSRI antidepressant, however, recent questions have cast a long and disquieting shadow over what many experts call a dangerous drug.

 

Several medical reports suggest that Zoloft may significantly increase the likelihood of neonatal birth defects when consumed by pregnant women. Specifically, Zoloft has been linked to such conditions as cleft palate, persistent pulmonary hypertension (PPHN), neurological defects, stomach conditions, and heart defects.

 

Are you concerned that in utero exposure to Zoloft (sertraline) may have caused your child’s birth defects? Find out all the answers to your questions by contacting the dangerous drug experts at Nachawati Law Group. With years of experience and dedicated expertise, we’re ready to advise you. We’re ready to fight for you!

 

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.